A Phase I Study of TQ-B3395 on Tolerance and Pharmacokinetics
Clinical trial NCT02944864 · TERMINATED
Trial details
- NCT number
- NCT02944864
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-13
- Primary completion
- 2021-05-23
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.